February 18, 2025
Rapid Dose Therapeutics Corp Announces Proposed Equity Private Placement FinancingSign up to get full access to all our latest Press Releases
Sign UpSign up to get full access to all our latest Press Releases
Sign UpRAPID DOSE THERAPEUTICS INC.
Listing/Symbol: CSE: DOSE
Fiscal Year-End: February 28
Auditors: SRCO Professional Corporation
Legal Counsel:
Harris & Harris
c/o Greg Harris
Share Structure
Shares issued & outstanding
Shares outstanding November 30, 2024
Common Shares 128,442,074
Reserved for issuance:
Warrants 27,893,393
Options 12,400,000
Fully diluted _______________
168,715,467
For inquiries
Email: [email protected]
Phone: 1 (416)-477-1052